Pulmonx (LUNG) Asset Writedowns and Impairment (2019 - 2025)
Pulmonx (LUNG) reported Asset Writedowns and Impairment of $46000.0 for Q2 2025, down 97.29% year-over-year from $1.7 million in Q2 2024, and up 200.0% quarter-over-quarter from -$46000.0 in Q1 2025.
Pulmonx (LUNG) Asset Writedowns and Impairment (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has 7 years of Asset Writedowns and Impairment data on file, last reported at $46000.0 in Q2 2025.
- Asset Writedowns and Impairment for Q2 2025 came in at $46000.0, down 97.29% year-over-year; the trailing twelve-month figure through Sep 2025 was -$200000.0 (down 109.69% YoY), and the FY2024 annual result was $40000.0, up 167.8% from the prior year.
- Asset Writedowns and Impairment climbed to $46000.0 in Q2 2025 per LUNG's latest filing, from -$46000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $1.7 million in Q2 2024 and troughed at -$968000.0 in Q4 2021.
- A 5-year average of $127388.9 and a median of $55000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
- On a YoY basis, Asset Writedowns and Impairment climbed as much as 722.71% in 2024 and fell as far as 20100.0% in 2024.
- A 5-year view of Asset Writedowns and Impairment shows it stood at -$968000.0 in 2021, then surged by 143.39% to $420000.0 in 2022, then sank by 99.76% to $1000.0 in 2023, then sank by 20100.0% to -$200000.0 in 2024, then jumped by 123.0% to $46000.0 in 2025.
- Business Quant data shows LUNG's Asset Writedowns and Impairment at $46000.0 in Q2 2025, -$46000.0 in Q1 2025, and -$200000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Pulmonx | 54.38 Mn | -15.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 46,000.00 |
| Jun 30, 2025 | 46,000.00 |
| Mar 31, 2025 | -46,000.00 |
| Mar 31, 2025 | -46,000.00 |
| Dec 31, 2024 | -200,000.00 |
| Dec 31, 2024 | -200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | 163,000.00 |
| Mar 31, 2024 | 163,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | -60,000.00 |
| Sep 30, 2023 | -60,000.00 |
| Jun 30, 2023 | -273,000.00 |
| Jun 30, 2023 | -273,000.00 |
| Mar 31, 2023 | 273,000.00 |
| Mar 31, 2023 | 273,000.00 |